Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders

Details for Australian Patent Application No. 2009225407 (hide)

Owner The General Hospital Corporation FluoroPharma, Inc.

Inventors Elmaleh, David R.; Shoup, Timothy; Fu, Hongning

Agent FB Rice

Pub. Number AU-A-2009225407

PCT Pub. Number WO2009/117728

Priority 61/038,571 21.03.08 US

Filing date 23 March 2009

Wipo publication date 24 September 2009

International Classifications

C07D 498/10 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

C07D 513/10 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

21 October 2010 PCT application entered the National Phase

  PCT publication WO2009/117728 Priority application(s): WO2009/117728

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009225416-Methods, devices and compositions for adhering hydrated polymer implants to bone

2009225393-File access via conduit application